Prosecution Insights
Last updated: April 19, 2026
Application No. 18/483,610

FLUID MANAGEMENT WITH ABNORMALITY DETECTION

Non-Final OA §102
Filed
Oct 10, 2023
Examiner
KIM, SUN U
Art Unit
1777
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Gyrus ACMI, Inc. D/B/A Olympus Surgical Technologies America
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
2y 11m
To Grant
90%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allow Rate
747 granted / 954 resolved
+13.3% vs TC avg
Moderate +11% lift
Without
With
+11.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
31 currently pending
Career history
985
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
47.2%
+7.2% vs TC avg
§102
21.6%
-18.4% vs TC avg
§112
17.5%
-22.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 954 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 8 is objected to because of the following informalities: Recitation of “inflow” in line 5 should be corrected to “outflow”. Appropriate correction is required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3, 11 and 19-22 are rejected under 35 U.S.C. 102(a)(1)/102(a)(2) as being anticipated by US 2021/0085158 A1 to Ikuma et al. (hereinafter “Ikuma”). Regarding claim 1, Ikuma discloses a system (fig. 1, 23) for detecting abnormalities in a medical device (endoscope) during a medical procedure in a patient (calculus removal), the system comprising: an inflow tubing 31 defining an inflow lumen, the inflow lumen configured to provide a fluid (saline) from a fluid source 27 to a site of the medical procedure (see paragraph [0101]); an inflow sensor 34 (flow meter) in communication with the inflow lumen to sense an inflow parameter (flow rate) of the fluid within the inflow lumen, the inflow sensor configured to generate an inflow signal indicative of the inflow parameter of the fluid (see paragraph [0101]); an outflow tubing 32 defining an outflow lumen, the outflow lumen configured to extract debris from the site of the medical procedure (see paragraph [0102]); an outflow sensor 35 in communication with the outflow lumen to sense an outflow parameter (flow rate) of the debris within the outflow lumen, the outflow sensor configured to generate an outflow signal indicative of the outflow parameter of the debris (see paragraph [0102]); a memory including instructions (see paragraphs [0091], [0262]-[0264]); and processing circuitry (see paragraphs [0091], [0262]-[0264]) that, when in operation, is configured by the instructions to: receive at least one of the inflow signal (saline flow rate) or the outflow signal (saline and debris flow rate); and identify an abnormality in either the inflow tubing or the outflow tubing based on comparing the inflow signal or the outflow signal, respectively, to pre-determined thresholds ([0262]: "the control unit may determine whether or not the flow rate in the conduit 32 has the threshold TH or less based on a detection signal from the flowmeter 35”). Regarding claim 2, Ikuma discloses an inflow pump 22 in communication with the inflow tubing 13 to control a fluid flow rate of the fluid through the inflow lumen; and an outflow pump 23 in communication with the outflow tubing 14 to control a debris flow rate of the debris through the outflow lumen (see Figure 1). Regarding claim 3, Ikuma discloses that the inflow signal (saline flow rate at flow meter 34: paragraph [0101]) and the outflow signal (saline and debris flow rate at flow meter 35: paragraph [0102]) are indicative of an inflow fluid flow rate and an outflow debris flow rate, respectively. Regarding claim 19, Ikuma discloses that the processing circuitry is configured to: transmit a controlling signal based on the abnormality measured in either the inflow tubing or the outflow tubing (see paragraphs [0262]-[0263]). Regarding claims 20-21, Ikuma discloses that the controlling signal alters a voltage supplied to the inflow pump 22 or the outflow pump 23 to change an inflow pumping rate of the inflow pump or an outflow pumping rate of the outflow pump (see paragraph [0265]: “the control unit can control a water feeding pump 22 or a suction pump 23 based on a detection signal” which implicitly altering voltage supplied to pump to change pumping rate). Regarding claim 22, Ikuma discloses a debris trap (the partition member 41 in the outflow tubing 14 in Figures 17-18) and the controlling signal opens the debris trap to clear the debris from the debris trap (see Figure 1; paragraphs [0213]-[0216]: the ultrasound transducer 37B in the outlet flow tubing 14 to prevent clogging of the outlet flow tubing 14). Claims 1-2 and 23-25 are rejected under 35 U.S.C. 102(a)(1)/102(a)(2) as being anticipated by US 2002/0019607 A1 (Bui). Regarding claim1, Bui discloses a system (fig. 1) suitable for detecting abnormalities (see paragraph [0018]: pressure deviation from desired pressure) in a medical device during a medical procedure in a patient (eye surgery), the system comprising: an inflow tubing 30 defining an inflow lumen (irrigation line), the inflow lumen configured to provide a fluid from a fluid source 32 to a site of the medical procedure; an inflow sensor 34, 44 in communication with the inflow lumen to sense an inflow parameter (pressure, [0013]-[0016]) of the fluid within the inflow lumen, the inflow sensor configured to generate an inflow signal indicative of the inflow parameter of the fluid; an outflow tubing 22 defining an outflow lumen (aspiration line 22: see paragraph [0011]), the outflow lumen configured to extract debris from the site of the medical procedure (see paragraph [0010]: "The aspiration system 16 removes the irrigation fluid and any detached tissue from the surgical site"); an outflow sensor 27 (see paragraph [0011]) in communication with the outflow lumen to sense an outflow parameter (pressure) of the debris within the outflow lumen, the outflow sensor configured to generate an outflow signal indicative of the outflow parameter of the debris; a memory including instructions (see paragraph [0013]); and processing circuitry that, when in operation, is configured by the instructions (see paragraph [0013]: "The controller 36 may include a microprocessor, memory, etc. that can receive input signals, process the signals in accordance with a software routine(s) and provide output signals.") to: receive at least one of the inflow signal or the outflow signal (see paragraphs [0013], [0018]); and identify an abnormality (see paragraph [0018]: "the actual pressure deviates from the desired pressure") in either the inflow tubing or the outflow tubing based on comparing the inflow signal or the outflow signal, respectively, to pre-determined thresholds (see paragraph [0018]: "desired range of pressures"). Regarding claim 2, Bui discloses an inflow pump 28 in communication with the inflow tubing 30 to control a fluid flow rate of the fluid through the inflow lumen; and an outflow pump 24 in communication with the outflow tubing 22 to control a debris flow rate of the debris through the outflow lumen (see paragraphs [0011]-[0012]). Regarding claim 23, Bui discloses a method for detecting abnormalities (see paragraph [0018]) in a medical device (fig. 1) during a medical procedure in a patient (eye surgery), the method comprising: receiving, from an inflow sensor 34, 44, an inflow signal indicative of one or more inflow parameters (pressure: see paragraphs [0013]-[0016]) of a fluid within an inflow lumen; receiving, from an outflow sensor 27, an outflow signal indicative of one or more outflow parameters (pressure) of debris within an outflow lumen (see paragraph [0010]: "The aspiration system 16 removes the irrigation fluid and any detached tissue from the surgical site"); identifying an abnormality (see paragraph [0018]: "the actual pressure deviates from the desired pressure") in the inflow lumen or the outflow lumen by comparing the inflow signal or the outflow signal to an inflow pre-determined threshold and an outflow pre-determined threshold, respectively (see paragraphs [0013], [0018]; and generating an inflow error or an outflow error based on the abnormality (see paragraph [0023]: "dividing the differential pressure across the system by the flowrate", the differential pressure being based on the actual, deviating pressure i.e. the abnormality) in the inflow lumen or the outflow lumen, respectively (see paragraphs [0020]-[0023], in particular [0023]: "If the actual resistance is greater than the threshold the controller 36 may activate a visual and/or audio indicator 54 to warn the surgeon that an occlusion may exist in the system."). Regarding claim 24, Bui discloses transmitting, via a display unit, the inflow error or the outflow error to a clinician performing the medical procedure (see paragraph [0023]: “If the actual resistance is greater than the threshold the controller 36 may activate a visual and/or audio indicator 54 to warn the surgeon that an occlusion may exist in the system”). Regarding claim 25, Bui discloses generating a controlling signal to alter one or more components of the medical device to mitigate the abnormality causing the inflow error or the outflow error (see paragraph [0018]: "If the actual pressure is outside the desired range the controller 36 can vary the pump speed, accordingly."). Allowable Subject Matter Claims 4-10 and 12-18 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN KIM whose telephone number is (571)272-1142. The examiner can normally be reached Maxi Flex. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, IN SUK BULLOCK can be reached at 571-272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /John Kim/Primary Examiner, Art Unit 1777 JK 2/11/26
Read full office action

Prosecution Timeline

Oct 10, 2023
Application Filed
Feb 11, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12601733
DEVICES FOR PERITONEAL DIALYSATE ANALYSIS
2y 5m to grant Granted Apr 14, 2026
Patent 12594368
PERITONEAL DIALYSIS SYSTEM USING DISINFECTION
2y 5m to grant Granted Apr 07, 2026
Patent 12594367
A SYSTEM AND METHOD FOR PRODUCING FLUID FOR PERITONEAL DIALYSIS
2y 5m to grant Granted Apr 07, 2026
Patent 12594369
WEIGHT-BASED PERITONEAL DIALYSIS SYSTEM INCLUDING A DRAIN TROLLEY
2y 5m to grant Granted Apr 07, 2026
Patent 12589192
PORTABLE DIALYSIS SYSTEM
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
90%
With Interview (+11.2%)
2y 11m
Median Time to Grant
Low
PTA Risk
Based on 954 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month